Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Deeds

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Disease Models & Mechanisms|July 6, 2013
Global gene expression profiling of pancreatic islets in mice during streptozotocin-induced β-cell damage and pancreatic Glp-1 gene therapyJason M Tonne, Toshie Sakuma, Michael C Deeds, et al.
Stem Cell Research & Therapy|November 18, 2011
Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cellsSeiga Ohmine, Allan B Dietz, Michael C Deeds, et al.
Aging|February 7, 2012
Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotencySeiga Ohmine, Karen A Squillace, Katherine A Hartjes, et al.
Cytotherapy|February 19, 2025
Fellowship training for cellular therapy laboratory directorsAshley A Krull, Margaret A DiGuardo, Michael C Deeds, et al.
Cytotherapy|January 4, 2022
Management of externally manufactured cell therapy products: the Mayo Clinic approachTimothy D Wiltshire, Michael C Deeds, Darcie J Radel, et al.
Cytotherapy|October 18, 2017
Mesenchymal stromal cells protect human cardiomyocytes from amyloid fibril damageYi Lin, Marta Marin-Argany, Christopher J Dick, et al.
Transplantation|January 5, 2011
Unique cellular and mitochondrial defects mediate FK506-induced islet β-cell dysfunctionNassir Rostambeigi, Ian R Lanza, Petras P Dzeja, et al.
Nature Communications|October 15, 2020
Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patientsMatthew S Block, Allan B Dietz, Michael P Gustafson, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Disease Models & Mechanisms|July 6, 2013
Global gene expression profiling of pancreatic islets in mice during streptozotocin-induced β-cell damage and pancreatic Glp-1 gene therapyJason M Tonne, Toshie Sakuma, Michael C Deeds, et al.
Stem Cell Research & Therapy|November 18, 2011
Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cellsSeiga Ohmine, Allan B Dietz, Michael C Deeds, et al.
Aging|February 7, 2012
Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotencySeiga Ohmine, Karen A Squillace, Katherine A Hartjes, et al.
Cytotherapy|February 19, 2025
Fellowship training for cellular therapy laboratory directorsAshley A Krull, Margaret A DiGuardo, Michael C Deeds, et al.
Cytotherapy|January 4, 2022
Management of externally manufactured cell therapy products: the Mayo Clinic approachTimothy D Wiltshire, Michael C Deeds, Darcie J Radel, et al.
Cytotherapy|October 18, 2017
Mesenchymal stromal cells protect human cardiomyocytes from amyloid fibril damageYi Lin, Marta Marin-Argany, Christopher J Dick, et al.
Transplantation|January 5, 2011
Unique cellular and mitochondrial defects mediate FK506-induced islet β-cell dysfunctionNassir Rostambeigi, Ian R Lanza, Petras P Dzeja, et al.
Nature Communications|October 15, 2020
Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patientsMatthew S Block, Allan B Dietz, Michael P Gustafson, et al.
Pageof 1